Home /ICON 6

ICON 6

Trial Description: 
A randomised trial of concurrent cediranib [AZD2171] (with platinum-based chemotherapy) and maintenance cediranib in women with platinum-sensitive relapsed ovarian cancer.
Lead Cooperative Group: 
NCRI
Participating Groups: 
ANZGOG
CCTG
GEICO
Trial Number: 

http://www.icon6.org/

ISRCTN68510403

ClinicalTrials.gov Identifier: NCT00532194

Disease Site: 
Recurrent Ovarian
Trial Status: 
Completed
Contact person: 
lfarrelly